LCA5

Clinical trials for LCA5 explained in plain language.

Never miss a new study

Get alerted when new LCA5 trials appear

Sign up with your email to follow new studies for LCA5, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental gene injection aims to halt rare blindness in kids and adults

Disease control Recruiting now

This study tests a gene therapy called OPGx-001 for people with vision loss caused by changes in the LCA5 gene. The treatment is a one-time injection under the retina. The main goals are to check safety and see if it can slow or stop vision from getting worse. The study includes …

Matched conditions: LCA5

Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

LCA5

Get alerted when new LCA5 trials appear

Experimental gene injection aims to halt rare blindness in kids and adults